Serum Institute has actually distanced itself from a controversial remark made by its officialThe Serum Institute has distanced itself from its executive director's statement that the Centre started the COVID-19 vaccination of several age groups without taking into account the available stock, mentioning that this is not the view of the company .
In a letter to the Union Health Ministry on May 22, Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Pune-based Serum Institute of India (SII), clarified that the statement by its executive director Suresh Jadav at a current occasion is not the view of the business, sources stated.
On behalf of our CEO Adar C Poonawalla, I wish to inform you that this statement is not released on behalf of SIIPL and the Business totally dissociates itself from this declaration.
It is repeated that, this is not the view of the business at all.
SIIPL is committed to increase its Covishield production and it stands shoulder to shoulder to strengthen the federal government's fight against COVID-19, he said in a communique.SII also clarified that Poonawalla is the only authorities representative of the company.Amid a severe scarcity of COVID-19 vaccines in the country, SII executive director Suresh Jadhav on Friday declared that the government started inoculating individuals from numerous age groups without taking into consideration the available stock of vaccines and the WHO standards.